Literature DB >> 26590253

Cathepsin S-Dependent Protease-Activated Receptor-2 Activation: A New Mechanism of Endothelial Dysfunction.

David J Nikolic-Paterson1.   

Abstract

Keywords:  PAR-2; cathepsin S; diabetic nephropathy; macrophage; therapy

Mesh：

Substances：

Year:  2015        PMID： 26590253      PMCID： PMC4884124          DOI： 10.1681/ASN.2015101162

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  16 in total

1.  Macrophage accumulation in human progressive diabetic nephropathy.

Authors:  Duy Nguyen; Fu Ping; Wei Mu; Prudence Hill; Robert C Atkins; Steven J Chadban
Journal:  Nephrology (Carlton)       Date:  2006-06       Impact factor: 2.506

2.  Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.

Authors:  F Y Chow; D J Nikolic-Paterson; E Ozols; R C Atkins; B J Rollin; G H Tesch
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

Review 3.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

4.  Increased serum cathepsin S in patients with atherosclerosis and diabetes.

Authors:  Jian Liu; Likun Ma; Jintian Yang; An Ren; Zimin Sun; Gengxing Yan; Jiusong Sun; Huanxian Fu; Weihua Xu; Chengcheng Hu; Guo-Ping Shi
Journal:  Atherosclerosis       Date:  2005-09-02       Impact factor: 5.162

5.  Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis.

Authors:  Hyunjae Chung; Rithwik Ramachandran; Morley D Hollenberg; Daniel A Muruve
Journal:  J Biol Chem       Date:  2013-11-19       Impact factor: 5.157

Review 6.  Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney.

Authors:  David A Vesey; John D Hooper; Glenda C Gobe; David W Johnson
Journal:  Nephrology (Carlton)       Date:  2007-02       Impact factor: 2.506

7.  Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.

Authors:  Fiona Chow; Elyce Ozols; David J Nikolic-Paterson; Robert C Atkins; Gregory H Tesch
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

8.  Protease-activated receptor-2 augments experimental crescentic glomerulonephritis.

Authors:  Leon Moussa; Jim Apostolopoulos; Piers Davenport; Jorge Tchongue; Peter G Tipping
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

9.  Pathway-selective antagonism of proteinase activated receptor 2.

Authors:  J Y Suen; A Cotterell; R J Lohman; J Lim; A Han; M K Yau; L Liu; M A Cooper; D A Vesey; D P Fairlie
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

10.  Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming.

Authors:  Khader Valli Rupanagudi; Onkar P Kulkarni; Julia Lichtnekert; Murthy Narayana Darisipudi; Shrikant R Mulay; Brigitte Schott; Sabine Gruner; Wolfgang Haap; Guido Hartmann; Hans-Joachim Anders
Journal:  Ann Rheum Dis       Date:  2013-12-03       Impact factor: 19.103
View more
  3 in total

1.  Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease-Activated Receptor-2, in Human Corneal Epithelial Cells.

Authors:  Wannita Klinngam; Runzhong Fu; Srikanth R Janga; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923

2.  Exploring the pathogenesis of diabetic kidney disease by microarray data analysis.

Authors:  Haiyan Cao; Xiaosheng Rao; Junya Jia; Tiekun Yan; Dong Li
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

3.  Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients.

Authors:  Maria C Edman; Srikanth R Janga; Zhen Meng; Mercy Bechtold; Alexander F Chen; Chongiin Kim; Luke Naman; Arunava Sarma; Neha Teekappanavar; Alice Y Kim; Sara Madrigal; Simranjit Singh; Elizabeth Ortiz; Stratos Christianakis; Daniel G Arkfeld; Wendy J Mack; Martin Heur; William Stohl; Sarah F Hamm-Alvarez
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.